Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5-β-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia

5-β-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia

US Patent 7138427 · Granted Nov 21, 2006

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sterilisation of S-nitrosothiols2019
Medical use of triazine derivatives2012
Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty a2012
Treatment of neurodegenerative conditions2011
Chemical compounds2009
Chemical compounds2009
5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment 2009
5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment 2009
5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment 2009
5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment 2009
5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment 2009
5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment 2009